US6436349B1
(en)
|
1991-03-04 |
2002-08-20 |
Bayer Corporation |
Fluid handling apparatus for an automated analyzer
|
US20060013729A1
(en)
*
|
1991-02-14 |
2006-01-19 |
Glen Carey |
Fluid handling apparatus for an automated analyzer
|
CA2384523C
(en)
*
|
1991-03-04 |
2007-01-09 |
Bayer Corporation |
Automated analyzer
|
US6498037B1
(en)
*
|
1991-03-04 |
2002-12-24 |
Bayer Corporation |
Method of handling reagents in a random access protocol
|
DE4123818C2
(de)
*
|
1991-07-18 |
1994-05-19 |
Berthold Lab Prof Dr |
Vorrichtung zur Messung der Chemilumineszenz einer in einem Probengefäß befindlichen Probe
|
EP0867511A1
(de)
*
|
1992-03-10 |
1998-09-30 |
La Jolla Cancer Research Foundation |
Rekombinierte alkalische Phosphatase aus Kälberdarm
|
DE69333230T2
(de)
|
1992-03-27 |
2004-08-05 |
Abbott Laboratories, Abbott Park |
Automatisches analysesystem mit ständigem und wahlfreiem zugriff und komponenten dafür
|
US6399397B1
(en)
*
|
1992-09-14 |
2002-06-04 |
Sri International |
Up-converting reporters for biological and other assays using laser excitation techniques
|
EP0628823A4
(de)
*
|
1992-11-20 |
1996-05-08 |
Dainabot Co Ltd |
Automatisches vielkanal immunotestsystem.
|
US5441894A
(en)
*
|
1993-04-30 |
1995-08-15 |
Abbott Laboratories |
Device containing a light absorbing element for automated chemiluminescent immunoassays
|
EP0651253A1
(de)
*
|
1993-11-02 |
1995-05-03 |
Abbott Laboratories |
Immunoassay zum Nachweis menschlicher Autoantikörper
|
US5468649A
(en)
*
|
1994-02-15 |
1995-11-21 |
Abbott Laboratories |
Process for labeling acridinium to microparticles and application in an instrument
|
US20010055581A1
(en)
*
|
1994-03-18 |
2001-12-27 |
Lawrence Tamarkin |
Composition and method for delivery of biologically-active factors
|
US5599501A
(en)
*
|
1994-11-10 |
1997-02-04 |
Ciba Corning Diagnostics Corp. |
Incubation chamber
|
JPH08136546A
(ja)
*
|
1994-11-15 |
1996-05-31 |
Bio Sensor Kenkyusho:Kk |
物質分析法
|
CA2222994A1
(en)
*
|
1995-06-07 |
1996-12-19 |
Abbott Laboratories |
Peptides for hiv-1 detection
|
US5686046A
(en)
*
|
1995-07-13 |
1997-11-11 |
Chiron Diagnostics Corporation |
Luminometer
|
US5735387A
(en)
*
|
1995-07-14 |
1998-04-07 |
Chiron Diagnostics Corporation |
Specimen rack handling system
|
US5720377A
(en)
*
|
1995-07-14 |
1998-02-24 |
Chiron Diagnostics Corporation |
Magnetic conveyor system
|
WO1997020947A1
(en)
*
|
1995-12-05 |
1997-06-12 |
University Of Utah Research Foundation |
Method of measuring chemical concentration based on spatial separation and resolution of luminescence
|
US20050202499A1
(en)
|
1996-10-31 |
2005-09-15 |
Billing-Medel Patricia A. |
Reagents and methods useful for detecting diseases of the breast
|
US6056923A
(en)
*
|
1997-06-25 |
2000-05-02 |
Clmp, Inc. |
Dual injector for chemiluminescence immunoanalyzing system
|
US6846905B2
(en)
|
1997-08-15 |
2005-01-25 |
Abbott Laboratories |
Antigen constructs useful in the detection and differentiation of antibodies to HIV
|
US7229841B2
(en)
*
|
2001-04-30 |
2007-06-12 |
Cytimmune Sciences, Inc. |
Colloidal metal compositions and methods
|
US6203974B1
(en)
|
1998-09-03 |
2001-03-20 |
Abbott Laboratories |
Chemiluminescent immunoassay for detection of antibodies to various viruses
|
US6686171B2
(en)
*
|
1999-05-10 |
2004-02-03 |
Tropix, Inc. |
Competitive chemiluminescent assay for cyclic nucleotide monophosphates
|
US6794156B2
(en)
*
|
1999-05-10 |
2004-09-21 |
Applera Corporation |
Cell growth, induction and lysis in an antibody-coated microplate for use in an ELISA
|
ES2165320B1
(es)
*
|
2000-05-03 |
2003-06-16 |
Dentaid S L |
Dispositivo optico para la cuantificacion de compuestos volatiles de azufre (cvs) a traves de medidas de absorcion/reflectancia.
|
AU2002231736A1
(en)
|
2000-12-22 |
2002-07-08 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Use of repulsive guidance molecule (rgm) and its modulators
|
DE10136865B4
(de)
*
|
2001-07-28 |
2007-11-15 |
Berthold Technologies Gmbh & Co. Kg |
Vorrichtung zur Messung der Chemilumineszenz
|
ES2339240T3
(es)
|
2002-07-26 |
2010-05-18 |
Abbott Laboratories |
Metodo para detectar y cuantificar el virus de la hepatitis c.
|
US20040024193A1
(en)
|
2002-07-26 |
2004-02-05 |
Williams Gregg T. |
Method of detecting and quantifying hepatitis C virus
|
US7920906B2
(en)
|
2005-03-10 |
2011-04-05 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US9247900B2
(en)
|
2004-07-13 |
2016-02-02 |
Dexcom, Inc. |
Analyte sensor
|
CN1960825A
(zh)
*
|
2004-01-28 |
2007-05-09 |
细胞免疫科学公司 |
官能化胶态金属组合物和方法
|
US20060270922A1
(en)
|
2004-07-13 |
2006-11-30 |
Brauker James H |
Analyte sensor
|
US8515516B2
(en)
|
2004-07-13 |
2013-08-20 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US20070037232A1
(en)
|
2005-03-31 |
2007-02-15 |
Barasch Jonathan M |
Detection of NGAL in chronic renal disease
|
US8624027B2
(en)
|
2005-05-12 |
2014-01-07 |
Abbvie Inc. |
Combination therapy for treating cancer and diagnostic assays for use therein
|
CN101277974A
(zh)
*
|
2005-09-30 |
2008-10-01 |
阿伯特有限及两合公司 |
排斥性引导分子(rgm)蛋白质家族的蛋白质的结合结构域及其功能性片段和它们的用途
|
US8865398B2
(en)
|
2006-09-01 |
2014-10-21 |
Abbott Laboratories |
Combination hepatitis C virus antigen and antibody detection method
|
US20080220448A1
(en)
*
|
2006-09-01 |
2008-09-11 |
Blincko Stuart J |
Antigenic protein conjugates and process for preparing same
|
US7776605B2
(en)
|
2006-10-26 |
2010-08-17 |
Abbott Laboratories |
Assay for cardiac troponin autoantibodies
|
EP2097750A2
(de)
*
|
2006-10-26 |
2009-09-09 |
Abbott Laboratories |
Immunoassay aus analyten in proben mit endogenen antikörpern gegen analyte
|
US20080305512A1
(en)
*
|
2006-10-26 |
2008-12-11 |
Mattingly Phillip G |
Assay for cardiac troponin autoantibodies
|
KR100824388B1
(ko)
*
|
2006-12-06 |
2008-04-22 |
한국타이어 주식회사 |
화학발광을 이용한 타이어 부위 별 노화측정방법
|
US7858924B2
(en)
|
2006-12-12 |
2010-12-28 |
Abbott Laboratories, Inc. |
Device for use in normalizing readings on a testing machine
|
US7914999B2
(en)
|
2006-12-29 |
2011-03-29 |
Abbott Laboratories |
Non-denaturing lysis reagent
|
JP5026849B2
(ja)
*
|
2007-04-20 |
2012-09-19 |
株式会社日立製作所 |
化学発光計測装置
|
CA2686867A1
(en)
|
2007-05-08 |
2008-11-13 |
Abbott Laboratories |
Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
|
JP5174898B2
(ja)
*
|
2007-05-24 |
2013-04-03 |
アボット・ラボラトリーズ |
疎水性薬物検体代謝産物との交差反応性が低下している免疫アッセイ
|
US20090053736A1
(en)
*
|
2007-08-21 |
2009-02-26 |
Mattingly Phillip G |
Homogeneous Chemiluminescent Immunoassay for Analysis of Iron Metalloproteins
|
US7608361B2
(en)
*
|
2007-08-22 |
2009-10-27 |
Stauffer John E |
Alkali metal battery
|
EP2033971A1
(de)
*
|
2007-09-06 |
2009-03-11 |
Abbott GmbH & Co. KG |
Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung
|
US20090068635A1
(en)
*
|
2007-09-06 |
2009-03-12 |
Muerhoff Anthony S |
Indirectly labelled assay conjugates and methods of preparing and using same
|
US8138318B2
(en)
|
2007-09-13 |
2012-03-20 |
Abbott Laboratories |
Hepatitis B pre-S2 nucleic acid
|
US20090098531A1
(en)
*
|
2007-09-13 |
2009-04-16 |
Abbott Laboratories |
Detecting hepatitis b virus
|
US20100136520A1
(en)
*
|
2007-09-13 |
2010-06-03 |
Abbott Laboratories |
Detecting hepatitis b virus
|
US20110014118A1
(en)
*
|
2007-09-21 |
2011-01-20 |
Lawrence Tamarkin |
Nanotherapeutic colloidal metal compositions and methods
|
EP2200932A4
(de)
*
|
2007-09-21 |
2014-09-10 |
Cytimmune Sciences Inc |
Nanotherapeutische kolloidale metallzusammensetzungen und verfahren
|
JP5746861B2
(ja)
|
2007-10-19 |
2015-07-08 |
アボット・ラボラトリーズAbbott Laboratories |
哺乳動物のngalに結合する抗体及びその使用
|
US20100267055A1
(en)
*
|
2007-10-21 |
2010-10-21 |
Abbott Laboratories |
One-step immunoassays exhibiting increased sensitivity and specificity
|
US8283124B2
(en)
*
|
2007-10-25 |
2012-10-09 |
Abbott Laboratories |
Compositions for detecting antibodies to Babesia microti and methods of uses thereof
|
EP2232264B1
(de)
|
2007-12-19 |
2015-12-02 |
Abbott Laboratories |
Immunsuppressivum-extraktionsreagens für immuntestverfahren
|
CN101387650B
(zh)
*
|
2007-12-20 |
2012-06-27 |
北京科美生物技术有限公司 |
全自动板式发光仪及其发光检测方法
|
DE202008009859U1
(de)
*
|
2007-12-21 |
2009-03-05 |
Berthold Technologies Gmbh & Co. Kg |
Vorrichtung zur wahlweisen Messung von insbesondere Lumineszenz- und/oder Fluoreszenzstrahlung
|
ES2539026T3
(es)
|
2007-12-27 |
2015-06-25 |
Abbott Laboratories |
Anticuerpos anti-T. cruzi y métodos de uso
|
WO2009086411A2
(en)
*
|
2007-12-27 |
2009-07-09 |
Abbott Laboratories |
Negative mimic antibody for use as a blocking reagent in bnp immunoassays
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
US8268981B2
(en)
|
2008-03-06 |
2012-09-18 |
Abbott Laboratories |
Plasmodium malariae and plasmodium ovale genes and uses thereof
|
US8030471B2
(en)
*
|
2008-03-06 |
2011-10-04 |
Abbott Laboratories |
Plasmodium malariae and Plasmodium ovale genes and uses thereof
|
BRPI0910482A2
(pt)
|
2008-04-29 |
2019-09-24 |
Abbott Lab |
imunoglobinas de domínio variável duplo e usos das mesmas
|
US20090286329A1
(en)
*
|
2008-05-19 |
2009-11-19 |
Abbott Laboratoires |
Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
|
US20090286256A1
(en)
*
|
2008-05-19 |
2009-11-19 |
Abbott Laboratories |
Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
|
JP2011523853A
(ja)
|
2008-06-03 |
2011-08-25 |
アボット・ラボラトリーズ |
二重可変ドメイン免疫グロブリン及びその使用
|
US20100015655A1
(en)
*
|
2008-07-17 |
2010-01-21 |
Abbott Laboratories |
Methods and Kits for Detecting and Quantifying Damage Caused by a Parasite
|
EP2326957B1
(de)
*
|
2008-09-03 |
2013-06-12 |
Abbott Molecular Inc. |
Tests und kits zur bestimmung von hiv-1-tropismus
|
US20100105150A1
(en)
*
|
2008-10-24 |
2010-04-29 |
Abbott Laboratories |
Isolated human autoantibodies to neutrophil gelatinase-associated lipocalin (ngal) and methods and kits for the detection of human autoantibodies to ngal
|
US8168165B2
(en)
|
2008-12-23 |
2012-05-01 |
Abbott Laboratories |
Alkylated interleukin-18 compositions
|
US8349325B2
(en)
|
2008-12-23 |
2013-01-08 |
Abbott Laboratories |
Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
|
US8241915B2
(en)
*
|
2009-01-14 |
2012-08-14 |
Abbott Laboratories |
Methods and kits for detecting hemoglobin in test samples
|
CN102365372B
(zh)
|
2009-01-31 |
2016-05-25 |
Abbvie公司 |
预测和监控对于Aurora激酶B抑制剂疗法的应答的标记
|
CN102388151A
(zh)
|
2009-02-11 |
2012-03-21 |
雅培制药有限公司 |
用于鉴定、分类和监控具有bcl-2家族抑制剂抗性肿瘤和癌症的受试者的方法和组合物
|
US8030026B2
(en)
|
2009-02-24 |
2011-10-04 |
Abbott Laboratories |
Antibodies to troponin I and methods of use thereof
|
EP3235509A1
(de)
|
2009-03-05 |
2017-10-25 |
AbbVie Inc. |
Il-17-bindende proteine
|
US8283162B2
(en)
|
2009-03-10 |
2012-10-09 |
Abbott Laboratories |
Antibodies relating to PIVKAII and uses thereof
|
US8063193B2
(en)
|
2009-03-27 |
2011-11-22 |
Abbott Laboratories |
Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof
|
CN201404734Y
(zh)
*
|
2009-04-28 |
2010-02-17 |
厦门市毕恩生物技术有限公司 |
底部控制式标本过滤容器
|
US20100291709A1
(en)
*
|
2009-05-13 |
2010-11-18 |
Abbott Laboratories |
Human nt-pro b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
|
US8183349B2
(en)
|
2009-06-30 |
2012-05-22 |
Abbott Laboratories |
Markers of XMRV infection and uses thereof
|
PE20121647A1
(es)
|
2009-08-29 |
2012-12-31 |
Abbvie Inc |
Proteinas terapeuticas de union a dll4
|
WO2011026017A1
(en)
|
2009-08-31 |
2011-03-03 |
Abbott Laboratories |
Biomarkers for prediction of major adverse cardiac events and uses thereof
|
JP5205354B2
(ja)
*
|
2009-09-30 |
2013-06-05 |
富士フイルム株式会社 |
クロマトグラフ測定装置
|
US8455212B2
(en)
*
|
2009-11-21 |
2013-06-04 |
Abbott Laboratories |
Assays for human NT-pro B-type natriuretic peptide, human pro B-type natriuretic peptide and human B-type natriuretic peptide
|
US8835120B2
(en)
|
2009-12-02 |
2014-09-16 |
Abbott Laboratories |
Assay for cardiac troponin-T (cTnT)
|
US8652788B2
(en)
*
|
2009-12-02 |
2014-02-18 |
Abbott Laboratories |
Assay for diagnosis of cardiac myocyte damage
|
US8183002B2
(en)
|
2009-12-03 |
2012-05-22 |
Abbott Laboratories |
Autoantibody enhanced immunoassays and kits
|
US20110136141A1
(en)
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Peptide reagents and method for inhibiting autoantibody antigen binding
|
PL2510001T3
(pl)
*
|
2009-12-08 |
2016-06-30 |
Abbvie Deutschland |
Monoklonalne przeciwciało przeciwko białku RGM A do zastosowania w leczeniu zwyrodnienia warstwy włókien nerwowych siatkówki (RNFL)
|
JP5964249B2
(ja)
|
2010-03-02 |
2016-08-03 |
アッヴィ・インコーポレイテッド |
治療用dll4結合タンパク質
|
US20110229921A1
(en)
*
|
2010-03-18 |
2011-09-22 |
Abbott Laboratories |
METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
|
WO2011129382A1
(en)
|
2010-04-16 |
2011-10-20 |
Abbott Japan Co. Ltd. |
Methods and reagents for diagnosing rheumatoid arthritis
|
JP5524698B2
(ja)
*
|
2010-04-27 |
2014-06-18 |
株式会社日立ハイテクノロジーズ |
自動分析装置
|
CN102236013A
(zh)
*
|
2010-04-28 |
2011-11-09 |
上海捷瑞医用试剂有限公司 |
化学发光免疫分析仪用浓缩缓冲液及其制备方法
|
US20120190563A1
(en)
|
2010-05-07 |
2012-07-26 |
Abbott Laboratories |
Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
|
EP2567232A1
(de)
|
2010-05-07 |
2013-03-13 |
AbbVie Inc. |
Verfahren zur vorhersage der sensitivität auf eine behandlung mit einem gezielten tyrosinkinasehemmer
|
TWI615405B
(zh)
|
2010-05-14 |
2018-02-21 |
艾伯維有限公司 |
Il-1結合蛋白
|
WO2011163558A1
(en)
|
2010-06-25 |
2011-12-29 |
Abbott Laboratories |
Materials and methods for assay of anti-hepatitis c virus (hcv) antibodies
|
US20120009196A1
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
CN103298834A
(zh)
|
2010-08-03 |
2013-09-11 |
Abbvie公司 |
双重可变结构域免疫球蛋白及其用途
|
US20120058462A1
(en)
|
2010-08-18 |
2012-03-08 |
Abbott Laboratories |
Molecular detection of xmrv infection
|
US20120058461A1
(en)
|
2010-08-18 |
2012-03-08 |
Abbott Laboratories |
Molecular detection of xmrv infection
|
AU2011293253B2
(en)
|
2010-08-26 |
2014-12-11 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
US20120115244A1
(en)
|
2010-11-09 |
2012-05-10 |
Abbott Laboratories |
Materials and methods for immunoassay of pterins
|
JP6009455B2
(ja)
|
2010-12-21 |
2016-10-19 |
アッヴィ・インコーポレイテッド |
Il−1アルファおよびベータ二重特異的二重可変ドメイン免疫グロブリンおよびその使用
|
SG192047A1
(en)
|
2011-01-24 |
2013-08-30 |
Univ Singapore |
Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins
|
EP2684048B1
(de)
|
2011-03-11 |
2018-10-03 |
Board of Regents of the University of Nebraska |
Biomarker für koronare herzkrankheit
|
JP2014515476A
(ja)
|
2011-05-20 |
2014-06-30 |
アボットジャパン株式会社 |
非特異的結合を減少させるためのイムノアッセイ方法及び試薬
|
US10641768B2
(en)
|
2011-07-08 |
2020-05-05 |
Abbott Japan Co. Ltd. |
Methods and kits for decreasing interferences from leukocytes in specific binding assays
|
WO2013009705A2
(en)
|
2011-07-09 |
2013-01-17 |
The Trustees Of Columbia University In The City Of New York |
Biomarkers, methods, and compositions for inhibiting a multi-cancer mesenchymal transition mechanism
|
CA2853258A1
(en)
|
2011-10-24 |
2013-05-02 |
Abbvie Inc. |
Immunobinders directed against sclerostin
|
SG11201401796SA
(en)
|
2011-10-24 |
2014-10-30 |
Abbvie Inc |
Bispecific immunobinders directed against tnf and il-17
|
AU2012352168C1
(en)
|
2011-12-14 |
2018-01-25 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
WO2013090633A2
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
JP2015508994A
(ja)
|
2011-12-30 |
2015-03-26 |
アッヴィ・インコーポレイテッド |
Il−13および/またはil−17に対する二重可変ドメイン免疫グロブリン
|
EP2797954A2
(de)
|
2011-12-30 |
2014-11-05 |
AbbVie Inc. |
Immunglobuline mit zweifacher variabler domäne und verwendungen davon
|
US8993248B2
(en)
|
2011-12-31 |
2015-03-31 |
Abbott Laboratories |
Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
|
IL305223A
(en)
|
2012-01-27 |
2023-10-01 |
Abbvie Inc |
The composition and method for the diagnosis and treatment of diseases related to the degeneration of nerve cells
|
TW201402608A
(zh)
|
2012-07-12 |
2014-01-16 |
Abbvie Inc |
Il-1結合蛋白質
|
US9618455B2
(en)
*
|
2012-08-20 |
2017-04-11 |
Siemens Healthcare Diagnostics Inc. |
Clam-shell luminometer
|
CN102798718A
(zh)
*
|
2012-08-31 |
2012-11-28 |
福建省洪诚生物药业有限公司 |
乙肝病毒前s1抗原检测试剂盒及其制备方法
|
BR112015009961B1
(pt)
|
2012-11-01 |
2020-10-20 |
Abbvie Inc. |
proteína de ligação capaz de se ligar a dll4 e vegf, bem como composição que a compreende como composição que a compreende
|
CA2890455A1
(en)
|
2012-12-04 |
2014-06-12 |
Abbvie, Inc. |
Blood-brain barrier (bbb) penetrating dual specific binding proteins
|
US9856319B2
(en)
|
2012-12-28 |
2018-01-02 |
Abbvie Inc. |
Monovalent binding proteins
|
EP2938634A2
(de)
|
2012-12-28 |
2015-11-04 |
AbbVie Inc. |
Spezifische doppeltbindende proteine mit einer rezeptorsequenz
|
US20140242077A1
(en)
|
2013-01-23 |
2014-08-28 |
Abbvie, Inc. |
Methods and compositions for modulating an immune response
|
US9651547B2
(en)
|
2013-03-14 |
2017-05-16 |
Abbott Point Of Care Inc. |
Electrochemical methods and devices for amending urine samples for immunosensor detection
|
US20140271453A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbott Laboratories |
Methods for the early detection of lung cancer
|
WO2014158272A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbott Laboratories |
Hcv antigen-antibody combination assay and methods and compositions for use therein
|
US9488663B2
(en)
|
2013-03-14 |
2016-11-08 |
Abbott Point Of Care Inc. |
Electrochemical methods and devices for amending urine samples for immunosensor detection
|
CN113549148A
(zh)
|
2013-03-14 |
2021-10-26 |
雅培制药有限公司 |
Hcv核心脂质结合结构域单克隆抗体
|
CA2906407A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbott Laboratories |
Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection
|
US9157910B2
(en)
|
2013-03-15 |
2015-10-13 |
Abbott Laboratories |
Assay with increased dynamic range
|
US9005901B2
(en)
|
2013-03-15 |
2015-04-14 |
Abbott Laboratories |
Assay with internal calibration
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
RU2015143833A
(ru)
|
2013-03-15 |
2017-04-21 |
Эббви Инк. |
СВЯЗЫВАЮЩИЕ БЕЛКИ С ДВОЙНОЙ СПЕЦИФИЧНОСТЬЮ, НАПРАВЛЕННЫЕ ПРОТИВ TNFα
|
US9062108B2
(en)
|
2013-03-15 |
2015-06-23 |
Abbvie Inc. |
Dual specific binding proteins directed against IL-1 and/or IL-17
|
WO2015031626A1
(en)
|
2013-08-28 |
2015-03-05 |
Abbvie Inc. |
Soluble cmet assay
|
EP3052524A2
(de)
|
2013-10-06 |
2016-08-10 |
Abbvie Inc. |
Spezifische doppelbindungsproteine gegen immunzellenrezeptoren und tlr-signalisierung von autoantigenen
|
WO2015103072A1
(en)
|
2013-12-30 |
2015-07-09 |
Epimab Biotherapeutics |
Fabs-in-tandem immunoglobulin and uses thereof
|
US20160002343A1
(en)
|
2014-06-11 |
2016-01-07 |
Abbvie Inc. |
Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
|
BR112016030008A2
(pt)
|
2014-06-27 |
2017-10-24 |
Abbott Lab |
método para a detecção de infecção por pegivirus humano 2 em um indivíduo, para a detecção de ácido nucleico de pegivirus humano 2 e para a detecção de pegivirus humano 2 em uma amostra, e, composição
|
WO2016069762A2
(en)
|
2014-10-29 |
2016-05-06 |
Abbott Laboratories |
Subject anti-hcv antibody detection assays employing ns3 capture peptides
|
WO2016094881A2
(en)
|
2014-12-11 |
2016-06-16 |
Abbvie Inc. |
Lrp-8 binding proteins
|
WO2016160976A2
(en)
|
2015-03-30 |
2016-10-06 |
Abbvie Inc. |
Monovalent tnf binding proteins
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
US20170089905A1
(en)
|
2015-09-28 |
2017-03-30 |
Abbott Japan Co., Ltd. |
Methods of diagnosing hepatocellular carcinoma and pancreatic cancer
|
CU24613B1
(es)
|
2016-02-06 |
2022-07-08 |
Epimab Biotherapeutics Inc |
Proteínas de unión a inmunoglobulinas fabs en tandem (fit-ig) biespecíficas que se unen a cmet y egfr
|
WO2017218911A1
(en)
|
2016-06-17 |
2017-12-21 |
Abbott Laboratories |
BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
|
MX2019001134A
(es)
|
2016-07-29 |
2019-04-11 |
Inst Tecnologico Estudios Superiores Monterrey |
Sistemas y metodos para la deteccion de reacciones quimioluminiscentes.
|
EP3279667A1
(de)
|
2016-08-02 |
2018-02-07 |
Abbott Laboratories |
Herz-troponin i und copeptin als biomarker für kurzfristige sterblichkeit bei akuter exazerbation von chronisch obstruktiver lungenerkrankung (aecopd)
|
WO2018027004A1
(en)
*
|
2016-08-03 |
2018-02-08 |
Pierce Biotechnology, Inc. |
Chemiluminescent and fluorescent substrate pads and uses thereof
|
US20180106800A1
(en)
|
2016-10-03 |
2018-04-19 |
Abbott Laboratories |
Methods of assessing uch-l1 status in patient samples
|
JP7346300B2
(ja)
|
2017-03-23 |
2023-09-19 |
アボット・ラボラトリーズ |
早期バイオマーカーであるユビキチンカルボキシ末端ヒドロラーゼl1を使用する、ヒト対象における外傷性脳損傷の程度の診断及び決定の一助となるための方法
|
CN106980024A
(zh)
*
|
2017-03-28 |
2017-07-25 |
杭州凯坤科技有限公司 |
一种全自动光激化学发光检测仪
|
CA3053409A1
(en)
|
2017-04-15 |
2018-10-18 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
JP7080899B2
(ja)
|
2017-04-28 |
2022-06-06 |
アボット・ラボラトリーズ |
同じヒト対象に由来する少なくとも2つの試料に対して早期バイオマーカーを使用する、外傷性脳損傷の超急性の診断及び決定の一助となるための方法
|
EP3631465A1
(de)
|
2017-05-25 |
2020-04-08 |
Abbott Laboratories |
Verfahren mit frühen biomarkern zur unterstützung bei der entscheidung, ob bei einer person, die eine kopfverletzung erlitten hat oder erlitten haben könnte, eine bildgebung durchgeführt werden soll
|
WO2018222783A1
(en)
|
2017-05-30 |
2018-12-06 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin i and early biomarkers
|
JP7454945B2
(ja)
|
2017-07-03 |
2024-03-25 |
アボット・ラボラトリーズ |
血液中のユビキチンカルボキシ末端ヒドロラーゼl1レベルを測定するための、改善された方法
|
BR112019028254A2
(pt)
|
2017-12-09 |
2020-07-14 |
Abbott Laboratories |
métodos para ajudar no diagnóstico e avaliação de um paciente que sofreu uma lesão ortopédica e que sofreu ou pode ter sofrido uma lesão na cabeça, tal como uma lesão cerebral traumática (lct) leve, usando a proteína ácida fibrilar glial (gfap) e/ou a hidrolase carbóxi-terminal da ubiquitina l1 (uch-l1)
|
BR112020010085A2
(pt)
|
2017-12-09 |
2020-10-13 |
Abbott Laboratories |
métodos para auxiliar no diagnóstico e avaliar uma lesão cerebral traumática em um indivíduo humano usando uma combinação de gfap e uch-l1
|
WO2019133717A1
(en)
|
2017-12-29 |
2019-07-04 |
Abbott Laboratories |
Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
|
WO2019151468A1
(ja)
*
|
2018-02-02 |
2019-08-08 |
日本ケミファ株式会社 |
生化学反応用基体及び分析装置
|
BR112020022035A2
(pt)
|
2018-04-30 |
2021-02-02 |
Takeda Pharmaceutical Company Limited |
proteínas de ligação de receptor de canabinoide tipo 1 (cb1) e usos das mesmas
|
EP3788377A1
(de)
|
2018-05-04 |
2021-03-10 |
Abbott Laboratories |
Hbv-diagnostische, prognostische und therapeutische verfahren und produkte
|
US11079395B2
(en)
|
2019-03-01 |
2021-08-03 |
Abbott Laboratories |
Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease
|
WO2021026403A1
(en)
|
2019-08-07 |
2021-02-11 |
Abbott Laboratories |
Methods for detecting assay interferents and increasing dynamic range
|
EP4136459A1
(de)
|
2020-04-13 |
2023-02-22 |
Abbott Laboratories |
Verfahren, komplexe und kits zum nachweis oder zur bestimmung einer menge eines ss-coronavirus-antikörpers in einer probe
|
CN111693514B
(zh)
*
|
2020-05-07 |
2022-07-05 |
四川轻化工大学 |
一种利用在线式液气转换的在线检测装置及方法
|
CA3188349A1
(en)
|
2020-08-04 |
2022-02-10 |
A. Scott Muerhoff |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
WO2022119841A1
(en)
|
2020-12-01 |
2022-06-09 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2022147178A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Improved methods, reagents and kits for detergent-based inactivation of betacoronavirus prior to and/or while assessing a biological sample for sars-cov-2 antigen or antibody
|
WO2022147147A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
BR112023024169A2
(pt)
|
2021-05-18 |
2024-02-06 |
Abbott Lab |
Métodos para avaliar lesão cerebral em um indivíduo pediátrico
|
CA3222291A1
(en)
|
2021-06-14 |
2022-12-22 |
Jaime MARINO |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
WO2023028186A1
(en)
|
2021-08-27 |
2023-03-02 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
WO2023034777A1
(en)
|
2021-08-31 |
2023-03-09 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023056268A1
(en)
|
2021-09-30 |
2023-04-06 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023129942A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2024044288A1
(en)
|
2022-08-26 |
2024-02-29 |
Abbott Laboratories |
Use of cardiac troponin and galectin-3 to differentiate myocardial infarction type i and type ii
|
WO2024059692A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|
WO2024102383A1
(en)
|
2022-11-10 |
2024-05-16 |
Abbott Laboratories |
Methods of identifying macrotroponin in biological samples
|